Literature DB >> 23669053

Can factors related to mortality be used to predict the follow-up health-related quality of life (HRQoL) in cardiac surgery patients?

Tarja Vainiola1, Risto P Roine, Raili Suojaranta-Ylinen, Antti Vento, Harri Sintonen.   

Abstract

BACKGROUND: Optimal selection of patients and choice of treatment methods in cardiac surgery calls for methods to predict outcome both in terms of mortality and health-related quality of life (HRQoL). Our target was to evaluate whether indicators predicting mortality can also be used to predict follow-up HRQoL.
METHODS: Preoperative and intensive care-related data of 571 elective cardiac surgery patients treated in the Helsinki University Central Hospital were used to predict, in a stepwise (forward) binary logistic regression, the probability of being dead at six months after operation. Furthermore, Tobit regression models were employed to predict the follow-up HRQoL of patients using also treatment complications and patients' experiences of pain and restlessness during treatment as explanatory variables.
RESULTS: The EuroSCORE, renal, respiratory and neurological complications as well as urgent sternotomy were all statistically significant predictors of mortality. By contrast, follow-up HRQoL was predicted by the baseline HRQoL, diabetes and male gender as well as experience of pain and restlessness during the ICU stay.
CONCLUSION: Mortality and HRQoL after cardiac surgery appear to be explained by different factors. Pain and restlessness during ICU treatment affect follow-up HRQoL in a negative manner and as potentially modifiable factors, need attention during treatment.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  15D; Cardiac surgery; Follow up; HRQoL; ICU

Mesh:

Year:  2013        PMID: 23669053     DOI: 10.1016/j.iccn.2013.04.003

Source DB:  PubMed          Journal:  Intensive Crit Care Nurs        ISSN: 0964-3397            Impact factor:   3.072


  7 in total

1.  A generic health-related quality of life instrument for assessing pelvic organ prolapse surgery: correlation with condition-specific outcome measures.

Authors:  Daniel Altman; Kirk Geale; Christian Falconer; Edward Morcos
Journal:  Int Urogynecol J       Date:  2018-03-06       Impact factor: 2.894

2.  Impact of marital status and comorbid disorders on health-related quality of life after cardiac surgery.

Authors:  Ann Kristin Bjørnnes; Monica Parry; Ragnhild Falk; Judy Watt-Watson; Irene Lie; Marit Leegaard
Journal:  Qual Life Res       Date:  2017-05-08       Impact factor: 4.147

Review 3.  Predictors of health-related quality of life after cardiac surgery: a systematic review.

Authors:  Julie Sanders; Tracey Bowden; Nicholas Woolfe-Loftus; Mandeep Sekhon; Leanne M Aitken
Journal:  Health Qual Life Outcomes       Date:  2022-05-18       Impact factor: 3.077

4.  The Effect of Classic Chest Physiotherapy on Postoperative Pain Scores and Hospital Stay in Patients Undergoing Off-Pump Coronary Artery Bypass Graft Surgery: A Randomized Clinical Trial.

Authors:  Mohammad Zolfaghari; Seyed Jalil Mirhosseini; Maryam Baghbeheshti; Brent A Bauer
Journal:  Galen Med J       Date:  2018-05-27

5.  Obstructive sleep apnoea, positive airway pressure treatment and postoperative delirium: protocol for a retrospective observational study.

Authors:  Christopher R King; Krisztina E Escallier; Yo-El S Ju; Nan Lin; Ben Julian Palanca; Sherry Lynn McKinnon; Michael Simon Avidan
Journal:  BMJ Open       Date:  2019-08-26       Impact factor: 2.692

6.  Patient features predicting long-term survival and health-related quality of life after radical surgery for non-small cell lung cancer.

Authors:  Ville Rauma; Jarmo Salo; Harri Sintonen; Jari Räsänen; Ilkka Ilonen
Journal:  Thorac Cancer       Date:  2016-01-21       Impact factor: 3.500

7.  Effect of physiotherapy on quality of life after coronary artery bypass graft surgery: A randomized study.

Authors:  Mohammad Zolfaghari; Seyyed Jalil Mirhosseini; Maryam Baghbeheshti; Alireza Afshani; Shadrooz Moazzam; Allahyar Golabchi
Journal:  J Res Med Sci       Date:  2018-06-06       Impact factor: 1.852

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.